Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "CA Guelph Holloway GP"

From Bioblast
Line 9: Line 9:
|Contact=Holloway Graham P
|Contact=Holloway Graham P
|MiPNetLab=Paglialunga Sabine
|MiPNetLab=Paglialunga Sabine
|Team previous=Perry Christopher GR, Snook Laelie
|Team previous=Perry Christopher GR, Snook Laelie, Herbst E
|Status=[http://www.oroboros.at/?Power-O2k '''3 Power-O2k'''] 2009-
|Status=[http://www.oroboros.at/?Power-O2k '''3 Power-O2k'''] 2009-
|info=[[MiP2013]], [[Bioblast 2012]], [http://oroboros.at/index.php?id=ioc54 IOC54]
|info=[[MiP2013]], [[Bioblast 2012]], [http://oroboros.at/index.php?id=ioc54 IOC54]

Revision as of 15:00, 11 August 2014

Template:MiPNetLab

Feedback

  • Thanks to you and the entire team for your outstanding assistance this year, and moreso for your pleasant friendliness. - Christopher G Perry (2013)
  • High resolution designs (i.e., O2k, OROBOROS Instruments) maximize respirometric sensitivity and precision (minimal O2 leak and highly sensitive electrodes), reducing the biological sample size required. Software advances in flux derivations of changes in chamber PO2 also permit real-time reporting of respiratory kinetics (Datlab, OROBOROS Instruments), which improves data analyses over other systems requiring visual assessments of steady-state kinetics. - Christopher G Perry, Kane DA, Lanza IR, Neufer PD (2013) Methods for assessing mitochondrial function in diabetes. Diabetes 62: 1041-1053. Β»PMID: 23520284